Abeona Therapeutics Inc. (ABEO) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Abeona Therapeutics Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
3.93
Strong
WeakModerateStrong
P/B Ratio
1.75
Strong
WeakModerateStrong
Earnings Yield
25.51%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
44.71%
Strong
WeakModerateStrong
Operating Margin
-1536.91%
Weak
WeakModerateStrong
Net Profit Margin
1223.08%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
-
No data
Net Income Growth
211.69%
Strong
WeakModerateStrong
EPS Growth
186.45%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
6.93
Strong
WeakModerateStrong
Quick Ratio
6.74
Strong
WeakModerateStrong
Asset Turnover
0.03x
Weak
WeakModerateStrong
Inventory Turnover
0.28x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-30.21%
Weak
WeakModerateStrong
EV / Free Cash Flow
-2.68x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.68x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
-0.797
Weak
WeakModerateStrong
Return on Invested Capital
-43.98%
Weak
WeakModerateStrong
Cash Conversion Cycle
-149.72 days
Strong
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for ABEO.
View Financial Statements